Hospital or health organisation · founded 1904
Fox Chase Cancer Center
Philadelphia, United States · foxchase.org
Part of Temple University Health System
- Citations, last 5 years
- 62.9k
- Works, last 5 years
- 4 126
- h-index
- 738
- Scientists listed
- 0
- Grants since 2016
- 606
Grants received
2020–2022 · research · R03
Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma
Alfonso Bellacosa · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
MTAP, 5'-deoxy-5'-methylthioadenosine, and the dysregulation of symmetric dimethylarginine in cancer
Warren D Kruger · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
MTAP, 5'-deoxy-5'-methylthioadenosine, and the dysregulation of symmetric dimethylarginine in cancer
Warren D Kruger · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2022 · research · R03
Comprehensive identification of RAS mutations and allelic co-segregation patterns in colorectal cancer
Ilya Serebriiskii · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · grant · DP2
New tools for understanding metastasis through tissue resident cells: enabling an Extensive Medicine strategy for metastatic disease
Joan Font-Burgada · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
MTAP, 5'-deoxy-5'-methylthioadenosine, and the dysregulation of symmetric dimethylarginine in cancer
Warren D Kruger · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2022 · research · R03
Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors
Jordan Mossler Anaokar · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2023 · contract · N01
TASK ORDER: PREVENTING LUNG CANCER BY TARGETING ACTIVATED STAT3
Margie Clapper · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2023 · research · R03
Comprehensive identification of RAS mutations and allelic co-segregation patterns in colorectal cancer
Ilya Serebriiskii · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · award
Sexual QOL Intervention for Couples Facing Metastatic Breast Cancer
Jennifer Reese · Fox Chase Cancer Center · funded by American Cancer Society
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2023 · research · R03
Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma
Alfonso Bellacosa · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
MTAP, 5'-deoxy-5'-methylthioadenosine, and the dysregulation of symmetric dimethylarginine in cancer
Warren D Kruger · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2022 · research · R21
Characterization of New Allosteric Inhibitors that Disrupt HIV-1 Integrase Dimerization
Mark David Andrake · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2021 · research · R03
Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors
Jordan Mossler Anaokar · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting RIPK3 in Flu-Associated Lung Injury
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2020 · award
APE1 cleansing of oxidatively damaged DNA ends
Amy Whitaker · Fox Chase Cancer Center · funded by American Cancer Society
2019–2022 · research · R01
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance
Stephen Matthew Sykes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting RIPK3 in Flu-Associated Lung Injury
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities
Camille C. Ragin · Fox Chase Cancer Center · funded by National Institutes of Health
2019 · contract · N01
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS (POP: 01/25/2019 -01/24/2024
(Contact) · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · career development · K99
Defining and targeting the metabolic landscape in Acute Myeloid Leukemia
Daniela Di Marcantonio · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · award
Harnessing pancreatic cancer’s stroma’s tumor suppressive functions
Jaye Gardiner · Fox Chase Cancer Center · funded by American Cancer Society
2019–2025 · research · R01
Targeting RIPK3 in Flu-Associated Lung Injury
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R21
A New IFN-γ Activated Cell Death Pathway in Salmonella-infected Non-Phagocytic Cells
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health